The Global Cardiac Arrhythmia Monitoring Devices Market is estimated to be valued at US$3.8 billion in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Cardiac arrhythmia monitoring devices are medical devices used to monitor and detect abnormal heart rhythms or arrhythmias....

The CAR T Cell Therapy Market is estimated to be valued at US$2.26 billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:CAR T cell therapy is a personalized immunotherapy that utilizes genetically modified T cells to target and kill cancer cells. This therapy has shown...

The global Cancer Biomarkers Market is estimated to be valued at US$ 21,643.9 million in 2023 and is expected to exhibit a CAGR of 14.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Cancer Biomarkers Market offers a wide range of products and services that aid in the diagnosis, prognosis, and treatment of various...

The Biosimilars Market is estimated to be valued at USD 21.8 billion in 2023 and is expected to exhibit a CAGR of 15.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: The Biosimilars Market offers cost-effective treatment options that are comparable to the originator biologics. These biosimilars are highly similar to the...

The Melatonin Market is estimated to be valued at US$ 436.8 Mn in 2019 and is expected to exhibit a CAGR of 7.2% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.Market Overview:Melatonin, a hormone naturally produced by the pineal gland, regulates the sleep-wake cycle. It is primarily used as a dietary supplement to treat sleep disorders...

The Meningococcal Vaccines Market is estimated to be valued at US$ 2,965.9 Mn in 2022 and is expected to exhibit a CAGR of 12.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.Market Overview:Meningococcal vaccines are effective in preventing meningococcal diseases, which include bacterial meningitis and septicemia. These vaccines...

The Monochloroacetic Acid (MCAA) Market is estimated to be valued at US$ 676.52 million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period of 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Monochloroacetic Acid (MCAA) is a versatile chemical compound used in various industries. It is widely used in the pharmaceutical...

The Network Access Control (NAC) market is estimated to be valued at US$ 9,397.7 Mn in 2021 and is expected to exhibit a CAGR of 8.2% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Network Access Control (NAC) is a crucial component of network security, offering authorized access to network resources. It helps...

The Neurological Biomarkers Market is estimated to be valued at US$ 8,979.6 Mn in 2021 and is expected to exhibit a CAGR of 14.7% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.Market Overview:The Neurological Biomarkers market refers to the use of specific biomolecules or characteristics that indicate the presence or progression of...

The Opioid Use Disorder Market is estimated to be valued at US$ 2,739.2 million in 2021 and is expected to exhibit a CAGR of 8.7% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.Market Overview:Opioid use disorder refers to a chronic condition characterized by the compulsive use of opioids, despite harmful consequences. This disorder...